Thus, this study aimed to explore the epidemiology, clinical characteristics, and OS of treatment-naïve ALK-positive advanced lung adenocarcinoma patients, focusing on smoking status and ALK-TKIs treatment, using a nationwide cancer registry database in Taiwan. This evidence concerns the gene ALK and lung adenocarcinoma.